925 related articles for article (PubMed ID: 33146673)
1. Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6.
Niu WH; Wu F; Cao WY; Wu ZG; Chao YC; Liang C
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33146673
[TBL] [Abstract][Full Text] [Related]
2. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
3. Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID-19.
Niu W; Wu F; Cui H; Cao W; Chao Y; Wu Z; Fan M; Liang C
Evid Based Complement Alternat Med; 2020; 2020():7493281. PubMed ID: 33204291
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Mechanism of Xiaoqinglong Decoction against COVID-19 Based on Network Pharmacology and Molecular Docking Technology.
Li HL; Zhou JP; Deng JM
Comb Chem High Throughput Screen; 2022; 25(13):2264-2277. PubMed ID: 35227178
[TBL] [Abstract][Full Text] [Related]
5. Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy.
Wang M; Fu D; Yao L; Li J
Comb Chem High Throughput Screen; 2021; 24(2):294-305. PubMed ID: 32767929
[TBL] [Abstract][Full Text] [Related]
6. Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma.
Qi F; Tang W
Biosci Trends; 2021 Sep; 15(4):201-204. PubMed ID: 34193750
[TBL] [Abstract][Full Text] [Related]
7. Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019.
Xing Y; Hua YR; Shang J; Ge WH; Liao J
Chin J Nat Med; 2020 Dec; 18(12):941-951. PubMed ID: 33357725
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.
Ye M; Luo G; Ye D; She M; Sun N; Lu YJ; Zheng J
Phytomedicine; 2021 May; 85():153401. PubMed ID: 33191068
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatical and Biochemical Analyses on the Protective Role of Traditional Chinese Medicine against Age-Related Macular Degeneration.
Cao Y; Li XY; Tchivelekete GM; Li X; Zhou X; He Z; Reilly J; Tan Z; Shu X
Curr Eye Res; 2022 Oct; 47(10):1450-1462. PubMed ID: 35947018
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
[TBL] [Abstract][Full Text] [Related]
11. New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches.
Jia K; Li Y; Liu T; Gu X; Li X
Chin Herb Med; 2023 Apr; 15(2):157-168. PubMed ID: 37220535
[TBL] [Abstract][Full Text] [Related]
12. Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC-MS
Zhang ZJ; Wu WY; Hou JJ; Zhang LL; Li FF; Gao L; Wu XD; Shi JY; Zhang R; Long HL; Lei M; Wu WY; Guo DA; Chen KX; Hofmann LA; Ci ZH
J Integr Med; 2020 May; 18(3):229-241. PubMed ID: 32307268
[TBL] [Abstract][Full Text] [Related]
13. Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research.
Wang J; Qi F
Drug Discov Ther; 2020; 14(3):149-150. PubMed ID: 32669523
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Huagan Decoction for reflux esophagitis.
Zhao Y; Cao Y; Yang X; Guo M; Wang C; Zhang Z; Zhang Q; Huang X; Sun M; Xi C; Tangthianchaichana J; Bai J; Du S; Lu Y
J Ethnopharmacol; 2022 Nov; 298():115629. PubMed ID: 35988839
[TBL] [Abstract][Full Text] [Related]
15. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.
Wang J; Ge W; Peng X; Yuan L; He S; Fu X
Mol Divers; 2022 Apr; 26(2):1175-1190. PubMed ID: 34105049
[TBL] [Abstract][Full Text] [Related]
16. Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network parmacology and molecular docking.
Tianyu Z; Liying G
Bioengineered; 2021 Dec; 12(1):2274-2287. PubMed ID: 34077310
[TBL] [Abstract][Full Text] [Related]
17. Study on the mechanism of treating COVID-19 with Shenqi Wan based on network pharmacology.
Ye XW; Deng YL; Zhang X; Liu MM; Liu Y; Xie YT; Wan Q; Huang M; Zhang T; Xi JH; Zhang JL
Drug Dev Ind Pharm; 2021 Aug; 47(8):1279-1289. PubMed ID: 34605344
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19.
Xia QD; Xun Y; Lu JL; Lu YC; Yang YY; Zhou P; Hu J; Li C; Wang SG
Cell Prolif; 2020 Dec; 53(12):e12949. PubMed ID: 33140889
[TBL] [Abstract][Full Text] [Related]
19. A bibliometric analysis of research related Chinese Medicine in the prevention and treatment of corona virus disease 2019.
Dayuan Z; Lan L; Luhua X; Huanjie L; Dahao C; Yumiao L; Dingxiang L; Yihui D
Heliyon; 2022 Nov; 8(11):e11120. PubMed ID: 36278116
[TBL] [Abstract][Full Text] [Related]
20. In silico analysis of the potential mechanism of a preventive Chinese medicine formula on coronavirus disease 2019.
Wu H; Gong K; Qin Y; Yuan Z; Xia S; Zhang S; Yang J; Yang P; Li L; Xie M
J Ethnopharmacol; 2021 Jul; 275():114098. PubMed ID: 33831468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
